Yuli Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Inflammasome and immune disorders
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
-
- Ubiquitin and proteasome pathways 5
- Advanced biosensing and bioanalysis techniques 4
- RNA Interference and Gene Delivery 4
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
- Oncology 13
- Cancer-related Molecular Pathways 6
- Peptidase Inhibition and Analysis 3
- Co-authors
- Yunshan Wang (8 shared papers)Guangwei Wei (6 shared papers)Claudia Kent (1 shared paper)Pengju Zhang (6 shared papers)Nancy L. Allbritton (3 shared papers)Jian‐Hua Mao (5 shared papers)Chuanxin Wang (4 shared papers)Lutao Du (4 shared papers)
- Journals
- Cancer Research (3 papers)Cancer Biology & Therapy (2 papers)Egyptian Journal of Biological Pest Control (2 papers)Scientific Reports (1 paper)Nature Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yuli Wang
49 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 277
- Molecular Biology 1.0k
- Oncology 358
- Immunology 242
- Biomaterials 121
Countries citing papers authored by Yuli Wang
This map shows the geographic impact of Yuli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Wang more than expected).
Fields of papers citing papers by Yuli Wang
This network shows the impact of papers produced by Yuli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Wang. The network helps show where Yuli Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuli Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 237 | |
| 2 | 2021 | 123 | |
| 3 | 2019 | 80 | |
| 4 | 2015 | 70 | |
| 5 | 2013 | 67 | |
| 6 | 2021 | 62 | |
| 7 | 2015 | 60 | |
| 8 | 1995 | 59 | |
| 9 | 2013 | 58 | |
| 10 | 2002 | 48 | |
| 11 | 2014 | 43 | |
| 12 | 2018 | 43 | |
| 13 | 2013 | 36 | |
| 14 | 2011 | 35 | |
| 15 | 2016 | 35 | |
| 16 | 2017 | 29 | |
| 17 | 2019 | 29 | |
| 18 | 2003 | 29 | |
| 19 | 2021 | 26 | |
| 20 | 2018 | 25 |
About Yuli Wang
Yuli Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Biomedical Engineering, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (277 citations), Molecular Biology (1.0k citations), Oncology (358 citations), Immunology (242 citations) and Biomaterials (121 citations). Yuli Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yunshan Wang, Guangwei Wei, Claudia Kent, Pengju Zhang, Nancy L. Allbritton, Jian‐Hua Mao, Chuanxin Wang, Lutao Du, Mingxin Wen and Theodore S. Lawrence. Their work appears in journals such as Cancer Research, Cancer Biology & Therapy, Egyptian Journal of Biological Pest Control, Scientific Reports and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.